Literature DB >> 20812010

Simian immunodeficiency virus-specific CD4+ T cells from successful vaccinees target the SIV Gag capsid.

Juan P Giraldo-Vela1, Alex T Bean, Richard Rudersdorf, Lyle T Wallace, John T Loffredo, Priscilla Erickson, Nancy A Wilson, David I Watkins.   

Abstract

We recently demonstrated that vaccinated rhesus macaques controlled viral replication of a heterologous SIV challenge. Here, we analyzed anamnestic SIV-specific CD4+ T-cell responses expanding immediately after challenge and show that successful vaccinees consistently targeted a short region of the Gag-p27 Capsid (amino acids 249-291). We have also defined the major histocompatibility complex class II (MHC-II) restricting alleles for several of these responses and show that DQ-restricted CD4+ T-cells depend on unique combinations of both the DQA and DQB alleles. Analysis of SIV-specific CD4+ T-cell responses elicited by a successful vaccine may have important implications in the understanding of vaccine design.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20812010      PMCID: PMC3018234          DOI: 10.1007/s00251-010-0473-9

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  27 in total

1.  Localization of CD4+ T cell epitope hotspots to exposed strands of HIV envelope glycoprotein suggests structural influences on antigen processing.

Authors:  S Surman; T D Lockey; K S Slobod; B Jones; J M Riberdy; S W White; P C Doherty; J L Hurwitz
Journal:  Proc Natl Acad Sci U S A       Date:  2001-04-03       Impact factor: 11.205

Review 2.  Epitope clusters in the major outer membrane protein of Chlamydia trachomatis.

Authors:  S K Kim; R DeMars
Journal:  Curr Opin Immunol       Date:  2001-08       Impact factor: 7.486

3.  Unprecedented polymorphism of Mhc-DRB region configurations in rhesus macaques.

Authors:  G G Doxiadis; N Otting; N G de Groot; R Noort; R E Bontrop
Journal:  J Immunol       Date:  2000-03-15       Impact factor: 5.422

4.  HIV preferentially infects HIV-specific CD4+ T cells.

Authors:  Daniel C Douek; Jason M Brenchley; Michael R Betts; David R Ambrozak; Brenna J Hill; Yukari Okamoto; Joseph P Casazza; Janaki Kuruppu; Kevin Kunstman; Steven Wolinsky; Zvi Grossman; Mark Dybul; Annette Oxenius; David A Price; Mark Connors; Richard A Koup
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

5.  Immunology and the elusive AIDS vaccine.

Authors:  Herbert W Virgin; Bruce D Walker
Journal:  Nature       Date:  2010-03-11       Impact factor: 49.962

6.  Comprehensive analysis of human immunodeficiency virus type 1-specific CD4 responses reveals marked immunodominance of gag and nef and the presence of broadly recognized peptides.

Authors:  Daniel E Kaufmann; Paul M Bailey; John Sidney; Bradford Wagner; Philip J Norris; Mary N Johnston; Lisa A Cosimi; Marylyn M Addo; Mathias Lichterfeld; Marcus Altfeld; Nicole Frahm; Christian Brander; Alessandro Sette; Bruce D Walker; Eric S Rosenberg
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

7.  Evolutionary stability of MHC class II haplotypes in diverse rhesus macaque populations.

Authors:  Gaby G M Doxiadis; Nel Otting; Natasja G de Groot; Nanine de Groot; Annemiek J M Rouweler; Riet Noort; Ernst J Verschoor; Ilja Bontjer; Ronald E Bontrop
Journal:  Immunogenetics       Date:  2003-10-18       Impact factor: 2.846

8.  HCV persistence and immune evasion in the absence of memory T cell help.

Authors:  Arash Grakoui; Naglaa H Shoukry; David J Woollard; Jin-Hwan Han; Holly L Hanson; John Ghrayeb; Krishna K Murthy; Charles M Rice; Christopher M Walker
Journal:  Science       Date:  2003-10-24       Impact factor: 47.728

9.  Genetic makeup of the DR region in rhesus macaques: gene content, transcripts, and pseudogenes.

Authors:  Nanine de Groot; Gaby G Doxiadis; Natasja G De Groot; Nel Otting; Corrine Heijmans; Annemiek J M Rouweler; Ronald E Bontrop
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

10.  Association of high HIV-1 RNA levels and homozygosity at HLA class II DRB1 in adults coinfected with Mycobacterium tuberculosis in Harare, Zimbabwe.

Authors:  Lynn S Zijenah; Wendy E Hartogensis; David A Katzenstein; Ocean Tobaiwa; Junior Mutswangwa; Peter R Mason; Leslie G Louie
Journal:  Hum Immunol       Date:  2002-11       Impact factor: 2.850

View more
  7 in total

1.  DNA/Ad5 vaccination with SIV epitopes induced epitope-specific CD4⁺ T cells, but few subdominant epitope-specific CD8⁺ T cells.

Authors:  Lara Vojnov; Alexander T Bean; Eric J Peterson; Maria J Chiuchiolo; Jonah B Sacha; Ferencz S Denes; Matyas Sandor; Deborah H Fuller; James T Fuller; Christopher L Parks; Adrian B McDermott; Nancy A Wilson; David I Watkins
Journal:  Vaccine       Date:  2011-08-10       Impact factor: 3.641

2.  Induction and comparison of SIV immunity in Ad5 naïve and Ad5 immune non-human primates using an Ad5 [E1-, E2b-] based vaccine.

Authors:  Elizabeth S Gabitzsch; Younong Xu; Joseph P Balint; Stephanie Balcaitis; Brigitte Sanders-Beer; Frank R Jones
Journal:  Vaccine       Date:  2011-08-22       Impact factor: 3.641

3.  Reduction of CD4+ T cells in vivo does not affect virus load in macaque elite controllers.

Authors:  Philip A Mudd; Adam J Ericsen; Andrew A Price; Nancy A Wilson; Keith A Reimann; David I Watkins
Journal:  J Virol       Date:  2011-05-18       Impact factor: 5.103

4.  Robust immunity to an auxotrophic Mycobacterium bovis BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model.

Authors:  Gerald K Chege; Wendy A Burgers; Helen Stutz; Ann E Meyers; Rosamund Chapman; Agano Kiravu; Rubina Bunjun; Enid G Shephard; William R Jacobs; Edward P Rybicki; Anna-Lise Williamson
Journal:  J Virol       Date:  2013-02-28       Impact factor: 5.103

5.  Vaccination with Gag, Vif, and Nef gene fragments affords partial control of viral replication after mucosal challenge with SIVmac239.

Authors:  Mauricio A Martins; Nancy A Wilson; Shari M Piaskowski; Kim L Weisgrau; Jessica R Furlott; Myrna C Bonaldo; Marlon G Veloso de Santana; Richard A Rudersdorf; Eva G Rakasz; Karen D Keating; Maria J Chiuchiolo; Michael Piatak; David B Allison; Christopher L Parks; Ricardo Galler; Jeffrey D Lifson; David I Watkins
Journal:  J Virol       Date:  2014-04-16       Impact factor: 5.103

6.  Polyinosinic-polycytidylic acid is the most effective TLR adjuvant for SIV Gag protein-induced T cell responses in nonhuman primates.

Authors:  Haesun Park; Lauren Adamson; Tae Ha; Karl Mullen; Shoko I Hagen; Arys Nogueron; Andrew W Sylwester; Michael K Axthelm; Al Legasse; Michael Piatak; Jeffrey D Lifson; Juliana M McElrath; Louis J Picker; Robert A Seder
Journal:  J Immunol       Date:  2013-03-15       Impact factor: 5.422

7.  Comparative analysis of SIV-specific cellular immune responses induced by different vaccine platforms in rhesus macaques.

Authors:  Antonio Valentin; Katherine McKinnon; Jinyao Li; Margherita Rosati; Viraj Kulkarni; Guy R Pilkington; Jenifer Bear; Candido Alicea; Diego A Vargas-Inchaustegui; L Jean Patterson; Poonam Pegu; Namal P M Liyanage; Shari N Gordon; Monica Vaccari; Yichuan Wang; Alison E Hogg; Blake Frey; Yongjun Sui; Steven G Reed; Niranjan Y Sardesai; Jay A Berzofsky; Genoveffa Franchini; Marjorie Robert-Guroff; Barbara K Felber; George N Pavlakis
Journal:  Clin Immunol       Date:  2014-09-16       Impact factor: 3.969

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.